X0306 4 2022-05-13 false 0001271214 Intersect ENT, Inc. XENT 0001308428 GALLAHUE KIERAN C/O INTERSECT ENT, INC. 1555 ADAMS DRIVE MENLO PARK CA 94025 true false false false Common Stock 2022-05-13 4 U false 3239.00 28.25 D 5011.00 D Common Stock 2022-05-13 4 U false 5011.00 28.25 D 0.00 D Common Stock 2022-05-13 4 U false 29262.00 28.25 D 0.00 I See Footnote Stock Option (right to buy) 25.10 2022-05-13 4 U false 120064.00 28.25 D 2029-05-06 Common Stock 120064.00 0.00 D Stock Option (right to buy) 21.00 2022-05-13 4 U false 3390.00 28.25 D 2031-03-15 Common Stock 3390.00 0.00 D Stock Option (right to buy) 17.01 2022-05-13 4 U false 82387.00 28.25 D 2029-09-29 Common Stock 82387.00 0.00 D Stock Option (right to buy) 16.50 2022-05-13 4 U false 5734.00 28.25 D 2031-06-02 Common Stock 5734.00 0.00 D Stock Option (right to buy) 13.79 2022-05-13 4 U false 12500.00 28.25 D 2026-06-01 Common Stock 12500.00 0.00 D Stock Option (right to buy) 11.84 2022-05-13 4 U false 9666.00 28.25 D 2030-06-03 Common Stock 9666.00 0.00 D Stock Options (Right to buy) 42.05 2022-05-13 4 U false 3473.00 28.25 D 2028-06-04 Common Stock 3473.00 0.00 D Stock Options (Right to buy) 26.05 2022-05-13 4 U false 6035.00 28.25 D 2027-05-31 Common Stock 6035.00 0.00 D Stock Options (Right to buy) 25.31 2022-05-13 4 U false 25000.00 28.25 D 2025-04-07 Common Stock 25000.00 0.00 D Stock Options (Right to buy) 13.05 2022-05-13 4 U false 13248.00 28.25 D 2027-01-17 Common Stock 13248.00 0.00 D Pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit that was subject to vesting conditions based solely on continued employment with or service to the Company or any of its subsidiaries (each, an 'Issuer RSU') that was outstanding and unvested immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer RSU and (2) the Common Stock Merger Consideration, subject to any required withholding of taxes. Reflects disposition of Issuer common stock in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger (the 'Merger Agreement'), dated August 6, 2021, by and among the Issuer, Medtronic, Inc. ('Parent') and Project Kraken Merger Sub, Inc., a wholly-owned subsidiary of Parent ('Merger Sub'), including the consummation of the merger (the 'Merger') between Issuer and Merger Sub on May 13, 2022. Pursuant to the Merger Agreement, as of the effective time of the Merger (the 'Effective Time'), [each outstanding share of Issuer common stock, $0.001 par value per share ('Issuer Common Stock'), was cancelled, retired and converted into the right to receive an amount equal to $28.25 in cash, without interest thereon (the 'Common Stock Merger Consideration'), subject to any required withholding of taxes]. The reportable securities are held by the Gallahue Irrevocable Trust. Pursuant to the Merger Agreement, at the Effective Time, each option granted by the Issuer to purchase Issuer Common Stock other than options subject to performance-based vesting conditions (each, an 'Issuer Option') that was outstanding and unexercised as of immediately prior to the Effective Time was cancelled and automatically converted into the right to receive an amount in cash equal to the product of (1) the aggregate number of Issuer Common Stock subject to such Issuer Option and (2) the excess, if any, of the Common Stock Merger Consideration over the exercise price of such Issuer Option, subject to any required withholding of taxes. /s/ Patrick A. Broderick, Attorney-in-Fact for Kieran T. Gallahue 2022-05-16